Personalized medicine is a medical model that uses medical decisions, practices, interventions and/or products that are tailored to the individual patient based on their predicted response or risk of disease.

RSK Medical Inc. brings a wealth of experience, knowledge, progressive learning and keen responsiveness as a medical device supplier and is dedicated to providing innovative and disruptive medical device technologies to the Canadian clinical community. These provide clinicians and hospitals with improved outcomes, preventative and therapeutic long-term care for their patients.

Based on strong clinical data and engineering, our products create and deliver substantial economic value to the health care system.

Latest News

electroCore Sapphire receives Adolescent Approval for migranes in Canada

October 6, 2021

It’s an absolute pleasure to share the news that gammaCore Sapphire now has the approval for adolescent migraine treatment in Canada. Specifically, our indication for use in Canada now reads;

gammaCore Sapphire (non-invasive vagus nerve stimulator) is indicated for:

  • Preventive treatment of cluster headache in adult patients.
  • Acute treatment of cluster headache in adult patients.

And now!

  • Preventive treatment of migraine headache in adolescent (age 12 and older) and adult patients.
  • Acute treatment of migraine headache in adolescent (age 12 and older) and adult patients.

New distribution agreement with ProCell Surgical Inc.

September 25, 2021

RSK Medical Inc. is pleased to announce a new nationwide distribution agreement with ProCell Surgical Inc. effective October 1st/2021. The ProCell device is a patient blood management system device used during surgical procedures requiring intraoperative autotransfusions. Their unique blood management system enhances a hospital’s surgical blood conservation efforts during surgery and provides added safety to the patient by utilizing their own blood vs. transfusions.

The ProCell has potential use in trauma, cardiac, vascular, transplant and orthopaedic surgical procedures. This product nicely complements RSK Medical current product portfolio serving these specialty surgical areas.

We look forward to introducing the unique and cost-effective ProCell technology across Canada.

First Patients in Canada Treated With Cardiovascular Systems, Inc. Diamondback 360® Coronary Orbital Atherectomy System

August 30, 2021

ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patients in Canada have been treated with its Diamondback 360®Coronary Orbital Atherectomy System (OAS).

The first patients in Canada were treated by Sanjog Kalra, MD, Interventional Cardiologist and Cardiac Critical Care Physician at the Peter Munk Cardiac Centre, Toronto General Hospital, part of the University Health Network.

Read more news from RSK Medical

Our People

Scott Kadwell

Scott Kadwell is the President of RSK Medical Inc. Over 40 plus years in the cardiovascular medical device business in Canada, he has held senior national business and marketing management positions with many of the largest global medical device companies such as SulzerMedica, Guidant, BSC, Medtronic and Sorin Group while residing in Calgary, Vancouver and Toronto.

The cardiovascular specialities related to his experience have been in the fields of interventional cardiology and radiology, electrophysiology, cardiac surgery and vascular/ endovascular therapies.

Scott was formerly an active member at MEDEC Association participating in a number of committees to develop policies, therapy awareness and financial reimbursement for new device technologies.

Dr. Frederick Kozak

Dr. Frederick Kozak is a Pediatric Otolaryngologist at BC Children’s Hospital and Clinical Professor in the Department of Surgery at the University of British Columbia. In his career of over twenty years, Dr. Kozak has been extensively involved as a clinician, researcher, medical educator and administrator.

His main clinical area of interest is hearing loss in the pediatric population and he is the Surgical/Medical Director of the Pediatric Cochlear Implant Program in B.C. He has published over 40 peer reviewed publications and he has presented his research and educational expertise locally, nationally and internationally. His extensive involvement in administrative committees includes being Vice-Chair and Chair of the Medical Advisory Committee for Children’s and Women’s Hospital of BC from 2002-2007.

Dr. Kozak has provided consultation to several pharmaceutical and device manufacturers over the past 20 years.

Gordon Collins

Gordon Collins is a Business Advisor, Executive Coach and Facilitator. Gordon is the president and founder of The Coaching Network based in Oakville, Ontario. He is also an associate with SGA – a consulting firm specializing in developing ‘C-Suite’ influencing capabilities globally and an adjunct faculty member of the Telfer Centre for Executive Leadership – University of Ottawa.

Gordon specializes in developing Business Effectiveness – through building leadership capability, creating team alignment and designing innovative approaches to creating competitive advantage. He has in-depth experience in the Private, Public and Non Profit sectors as well as a global practice across North and South America, Europe, Middle East, Asia Pacific and Africa.

Gordon has provided consultation to a large number of medical device, biotech and pharmaceutical companies across North America and Europe over the past 20 years.

PO Box 30040 RPO Boxgrove
90 Copper Creek Dr.
Markham, Ontario
L6B 0R5 Canada